Funding

Beactica Therapeutics AB

Sweden · Biotech · AI · Enterprise software

Develops precision immune therapies for glioblastoma

Visit beactica.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Strategic€2.5MEuropean Innovation Council — Role not disclosed

Investors

European Innovation CouncilStrategic

Coverage

Feb 17, 2026Beactica Therapeutics AB · Strategic

Similar companies

Estuary BiotherapeuticsEstuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.$93M · Series A
GasLabGasLab is developing a generative music platform that links AI-created tracks to participating artists and rights holders so they can share in the revenue.~$1M · Pre-seed
HoloHolo helps small businesses plan marketing campaigns, create content and publish it across connected channels.€5M · Seed
Sourcesbeactica.com ↗